As reported in all the major news outlets, Mylan has come under fire for major price increases on its EpiPen, which counteracts the allergic reaction known as anaphylaxis. The latest development as reported by NBC News said the company has also raised prices on dozens of other drugs as well.
According to the NBC News article, the price for an EpiPen has increased fivefold since 2008, with some patients paying more than $600 for a package of two devices.
"Mylan has raised the prices more than 20 percent on 24 products, and more than 100 percent on seven products," said Wells Fargo senior analyst David Maris. He also mentioned CEO Heather Bresch's compensation increased by nearly 700 percent from 2007 to 2015. Read the full story